Category: <span>Tazemetostat</span>

Mesothelioma Clinical Trial for Tazemetostat Launches in US

City of Hope cancer center thoracic oncologist Dr. Marianna Koczywas explains the workings of tazemetostat — the latest drug tested in a mesothelioma clinical trial — with the lock and key metaphor. “You have a specific [cancer] key, and a specific keyhole it goes through. If you can lock that keyhole, you can lock it…

The post Mesothelioma Clinical Trial for Tazemetostat Launches in US appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Epizyme Testing New Mesothelioma Treatment with Phase Two Clinical Trial

Biopharmaceutical company Epizyme, Inc. is starting a new phase two clinical trial using tazemetostat as a treatment for mesothelioma cancer.